OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
46
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. OnKure Therapeutics Inc. market cap is $46.06M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. OnKure Therapeutics Inc. 52 week high is $92.10 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. OnKure Therapeutics Inc. 52 week low is $9.80 as of November 22, 2026.
OnKure Therapeutics Inc. stock price today is $18.10.
OnKure Therapeutics Inc. stock price yesterday was $17.30.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. OnKure Therapeutics Inc.'s P/E ratio is -10.8.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. OnKure Therapeutics Inc. P/B ratio is 7.9129.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. OnKure Therapeutics Inc. 50-day moving average is $14.93.